SYS6005

· CSPC Megalith Biopharmaceutical Co.,Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SYS6005, covering 2025-05-14 to 2025-05-14. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of SYS6005 in Patients With Advanced Malignant Tumor [Phase 1]